EHC
Encompass Health Corp
NYSE: EHC · HEALTHCARE · MEDICAL CARE FACILITIES
$102.61
+0.90% today
Updated 2026-04-29
Market cap
$10.20B
P/E ratio
18.49
P/S ratio
1.72x
EPS (TTM)
$5.55
Dividend yield
0.71%
52W range
$93 – $128
Volume
0.9M
WallStSmart proprietary scores
70
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+5.8
Quality
C+7.5
Profitability
B+8.0
Valuation
A4/9
Piotroski F-Score
Moderate
2.1
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$142.73
+39.10%
12-Month target
$97.72
-4.77%
Intrinsic (DCF)
$147.31
Margin of safety
+23.00%
1 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 24.80% — strong efficiency
+ Free cash flow $116.70M — positive
+ 23.00% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.35B | $4.80B | $5.37B | $5.94B | $5.94B |
| Net income | $271.00M | $352.00M | $455.70M | $566.20M | $146.10M |
| EPS | — | — | — | — | $5.55 |
| Free cash flow | $121.70M | $267.70M | $360.30M | $439.20M | $116.70M |
| Profit margin | 6.23% | 7.33% | 8.48% | 9.54% | 9.54% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-16 | REIDY, CHRISTOPHER R | Buy | 334 | $106.48 |
| 2026-04-16 | CHRISTIE, EDWARD M III | Buy | 261 | $106.17 |
| 2026-04-15 | WILLIAMS, TERRANCE | Buy | 27 | — |
Peer comparison
Smart narrative
Encompass Health Corp trades at $102.61. representing a P/E of 18.49x trailing earnings. Our Smart Value Score of 70/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.09, it sits in the grey zone. TTM revenue stands at $5.94B. with profit margins at 9.54%. Our DCF model estimates intrinsic value at $147.31.
Frequently asked questions
What is Encompass Health Corp's stock price?
Encompass Health Corp (EHC) trades at $102.61.
Is Encompass Health Corp overvalued?
Smart Value Score 70/100 (Grade B, Buy). DCF value $147.31.
What is the price target of Encompass Health Corp (EHC)?
The analyst target price is $142.73, representing +39.1% upside from the current price of $102.61.
What is the intrinsic value of Encompass Health Corp (EHC)?
Based on our DCF model, intrinsic value is $147.31, a +23.0% margin of safety versus $102.61.
What is Encompass Health Corp's revenue?
TTM revenue is $5.94B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.09 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.72x
ROE24.80%
Beta0.60
50D MA$103.42
200D MA$111.52
Shares out0.10B
Float0.10B
Short ratio—
Avg volume0.9M
Performance
1 week+2.00%
1 month+6.85%
3 months+4.37%
YTD+1.05%
1 year—
3 years—
5 years—